A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Pain|Bone Neoplasm|Neoplasm Metastasis
Interventions: DRUG: ibandronate [Bondronat]
Sponsor: Hoffmann-La Roche